IwataniAyako Metagen Therapeutics, Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; President & CEO: Taku Nakahara) launched a new logo and brand identity, driven by its purpose of “living up to the hopes of patients through microbiome science,” and its focus of creating a Health Sharing Community centered on gut microbiota donation.
◾️ Creating a Community Where Health is Shared Through Gut Microbiota Donation
Metagen Therapeutics is pioneering medical technologies and drug development using gut microbiota sourced from stool donors. By establishing a Gut Microbiome Bank, the company is driving innovation in healthcare. In April 2025, Japan’s first stool donation facility will open in Tsuruoka City, Yamagata Prefecture, marking a significant step in expanding donor awareness and participation.
Beyond advancing treatment and drug discovery, gut microbiota donation lays the foundation for a new culture of shared health. To reflect this vision, Metagen Therapeutics has introduced a new logo that embodies the concept of a Health Sharing Community, where health is passed from person to person with gut microbiota.
Looking ahead, the company is committed to promoting stool donation, enhancing accessibility, and collaborating with diverse industry partners to create a society where people actively support each other’s health.
◾️ A New Brand Symbol Inspired by Fresh Perspectives and the Power of a Torch
Metagen Therapeutics’ logo redesign is built around two key elements. A full corporate website renewal is also planned for April 2025.
① A Fresh Perspective on Gut Microbiota
The design reflects our commitment to reexamining gut microbiota—organisms that predate humanity itself—through the lens of technology and science. By approaching gut microbiota from a new angle, we aim to drive innovation in medicine and redefine the meaning of health through stool donation.
②A Torch Symbolizing a New Health Community
The torch represents a movement where the value of gut microbiota is widely shared, fostering a culture where health is passed from person to person. This symbolizes our vision of expanding the gut microbiota donation system and creating opportunities for broader participation in this transformative healthcare approach.
About Metagen Therapeutics, Inc.
Metagen Therapeutics, Inc., is a biotech startup originating from Juntendo University, Keio University, and Tokyo University of Science. It aims to create social impact through medicine and drug discovery based on gut microbiota research, with the purpose of “living up to the hopes of patients through microbiome science.” Utilizing the company’s Gut Microbiome Bank as the foundation for sourcing ingredients, the company runs the Medical Service Business and Drug Discovery Business to make Fecal Microbiota Transplantation (FMT) the global standard of treatment. Currently, the company focuses on developing treatments for immune diseases (inflammatory bowel disease), cancer, and central nervous system diseases.